Françoise Meunier: High-Level Conference on Ending Financial Discrimination Against Cancer Survivors
Françoise Meunier announced on LinkedIn:
“I would like to invite you to the High-Level Conference on Ending Financial Discrimination Against Cancer Survivors that I am organizing on 15. February 2024 in Brussels!
I have prepared a video showing you the Palace of the Academies in Brussels, where the conference will be hosted.
Please click here to watch it.
You will find all the details and a registration link for the conference here. I look forward to seeing you in February!”
Source: Françoise Meunier/LinkedIn
Françoise Meunier dedicated her professional life to improving the survival and QoL of cancer patients. Prof. Meunier served as Director-General of the European organization for Research and Treatment of Cancer (1991-2015), where she remained active until 2018 as Director of Special Projects, being the driving force behind cancer survivorship activities.
Since 2014, she has been pursuing activities on the Right to be Forgotten for cancer survivors, advocating for the creation of a harmonised legal framework to tackle discrimination against cancer survivors. Prior to joining the EORTC, Françoise Meunier was Head of Infectious Diseases Department at Institute Jules Bordet.
Prof. Meunier was awarded the Belgian Laureate Prix Femmes d’Europe 2004-2005, conferred the title of Baroness by His Majesty, King Albert II of Belgium in 2007, received the Pezcoller Foundation award in 2009, became a Fellow of the European Academy of Cancer Sciences in 2011, joined the Scientific Committee of the Innovative Medicine Initiative of the European Union in 2012, received the ECCO Life time achievement award in 2013, awarded a Ben de Pauw Medal for her dedication to Medical Mycology in 2013, appointed council member of the Federation of European Academies of Medicine in 2014, appointed Chair of Accreditation Council of Oncology in Europe and Member of Alliance for Biomedical Research in Europe in 2015, and has been a member of the Belgian Royal Academy of Medicine since 2006.